Translational upregulation of Aurora-A by hnRNP Q1 contributes to cell proliferation and tumorigenesis in colorectal cancer

  • Chien Hsien Lai
  • , Yu Chuan Huang
  • , Jenq Chang Lee
  • , Joseph Ta Chien Tseng
  • , Kung Chao Chang
  • , Yen Ju Chen
  • , Nai Jhu Ding
  • , Pao Hsuan Huang
  • , Wen Chang Chang
  • , Bo Wen Lin
  • , Ruo Yu Chen
  • , Yu Chu Wang
  • , Yi Chien Lai
  • , Liang Yi Hung

Research output: Contribution to journalArticlepeer-review

28 Citations (Scopus)

Abstract

By using RNA-immunoprecipitation assay following next-generation sequencing, a group of cell cycle-related genes targeted by hnRNP Q1 were identified, including Aurora-A kinase. Overexpressed hnRNP Q1 can upregulate Aurora-A protein, but not alter the mRNA level, through enhancing the translational efficiency of Aurora-A mRNA, either in a cap-dependent or -independent manner, by interacting with the 5′-UTR of Aurora-A mRNA through its RNA-binding domains (RBDs) 2 and 3. By ribosomal profiling assay further confirmed the translational regulation of Aurora-A mRNA by hnRNP Q1. Overexpression of hnRNP Q1 promotes cell proliferation and tumor growth. HnRNP Q1/ΔRBD23-truncated mutant, which loses the binding ability and translational regulation of Aurora-A mRNA, has no effect on promoting tumor growth. The expression level of hnRNP Q1 is positively correlated with Aurora-A in colorectal cancer. Taken together, our data indicate that hnRNP Q1 is a novel trans-acting factor that binds to Aurora-A mRNA 5′-UTRs and regulates its translation, which increases cell proliferation and contributes to tumorigenesis in colorectal cancer.

Original languageEnglish
Article numbere2555
JournalCell Death and Disease
Volume8
Issue number1
DOIs
Publication statusPublished - 2017

ASJC Scopus subject areas

  • Immunology
  • Cellular and Molecular Neuroscience
  • Cell Biology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Translational upregulation of Aurora-A by hnRNP Q1 contributes to cell proliferation and tumorigenesis in colorectal cancer'. Together they form a unique fingerprint.

Cite this